Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast - María Díez Campelo, MD, PhD - Exploring Unmarked Territory in MDS: Taking Command and Enhancing Care With Team-Based Diagnosis and Treatment

María Díez Campelo, MD, PhD - Exploring Unmarked Territory in MDS: Taking Command and Enhancing Care With Team-Based Diagnosis and Treatment

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

01/17/24 • 99 min

plus icon
bookmark
Share icon
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/BWR865. CME/MOC credit will be available until December 31, 2024.

Exploring Unmarked Territory in MDS: Taking Command and Enhancing Care With Team-Based Diagnosis and Treatment

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.

Support
This activity is supported through educational grants from Astex Pharmaceuticals, Inc., Bristol Myers Squibb, Geron, Karyopharm Therapeutics, and Novartis Pharmaceuticals Corporation.

Disclosures
María Díez Campelo, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Agios Pharmaceuticals Inc.; Blueprint Medicines; Bristol Myers Squibb; GlaxoSmithKline; Hemavant Sciences; Novartis; and Syros Pharmaceuticals, Inc.

Rory M. Shallis, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Bristol Myers Squibb; Curio Bioscience; Gilead Sciences, Inc.; Rigel Pharmaceuticals, Inc.; and Servier Pharmaceuticals.

Aditi Shastri, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Kymera Therapeutics; and Rigel Pharmaceuticals, Inc.
Grant/Research Support from Kymera Therapeutics.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.
Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.

01/17/24 • 99 min

plus icon
bookmark
Share icon

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/peerview-oncology-and-hematology-cmecnecpe-audio-podcast-25436/mar%c3%ada-d%c3%adez-campelo-md-phd-exploring-unmarked-territory-in-mds-taking-c-42254387"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to maría díez campelo, md, phd - exploring unmarked territory in mds: taking command and enhancing care with team-based diagnosis and treatment on goodpods" style="width: 225px" /> </a>

Copy